Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anaplastic Cancer: Our Experience.
Kanteti APK, Ghose J, Patil VM, Tamhankar AS, Abraham G, Noronha V, Laskar SG, Menon NS, Pai PS, Prabhash K. Kanteti APK, et al. Among authors: menon ns. Indian J Surg Oncol. 2022 Dec;13(4):789-796. doi: 10.1007/s13193-022-01576-w. Epub 2022 Jul 6. Indian J Surg Oncol. 2022. PMID: 36687234 Free PMC article.
Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer.
Patil V, Noronha V, Joshi A, Chougule A, Kannan S, Bhattacharjee A, Goud S, More S, Chandrasekharan A, Menon N, Srinivas S, Vallathol DH, Dsouza H, Majumdar S, Das S, Zawar A, Khaddar S, Kumar A, Singh G, Kumar KAP, Ravind R, Trivedi V, Behel V, Mahajan A, Janu A, Purandare N, Prabhash K. Patil V, et al. EClinicalMedicine. 2019 Apr 9;9:19-25. doi: 10.1016/j.eclinm.2019.03.011. eCollection 2019 Mar. EClinicalMedicine. 2019. PMID: 31143878 Free PMC article.
NUT Midline Carcinoma.
Patil VM, Toshniwal A, Noronha V, Joshi A, Menon N, Banavali S, Prabhash K. Patil VM, et al. Clin Oncol (R Coll Radiol). 2019 Oct;31(10):732. doi: 10.1016/j.clon.2019.06.012. Epub 2019 Jul 19. Clin Oncol (R Coll Radiol). 2019. PMID: 31331817 No abstract available.
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer.
Noronha V, Patil VM, Joshi A, Menon N, Chougule A, Mahajan A, Janu A, Purandare N, Kumar R, More S, Goud S, Kadam N, Daware N, Bhattacharjee A, Shah S, Yadav A, Trivedi V, Behel V, Dutt A, Banavali SD, Prabhash K. Noronha V, et al. J Clin Oncol. 2020 Jan 10;38(2):124-136. doi: 10.1200/JCO.19.01154. Epub 2019 Aug 14. J Clin Oncol. 2020. PMID: 31411950 Clinical Trial.
Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer.
Patil VM, Noronha V, Joshi A, Dhumal S, Mahimkar M, Bhattacharjee A, Gota V, Pandey M, Menon N, Mahajan A, Sable N, Kumar S, Nawale K, Mukadam S, Solanki B, Das S, Simha V, Abraham G, Chandrasekharan A, Talreja V, DSouza H, Srinivas S, Kashyap L, Banavali S, Prabhash K. Patil VM, et al. J Clin Oncol. 2019 Nov 10;37(32):3032-3041. doi: 10.1200/JCO.19.01076. Epub 2019 Sep 20. J Clin Oncol. 2019. PMID: 31539316 Clinical Trial.
Reply to T. Tanaka et al and F. Liang.
Noronha V, Patil VM, Joshi A, Menon N, Chougule A, Prabhash K. Noronha V, et al. J Clin Oncol. 2020 Mar 10;38(8):844-846. doi: 10.1200/JCO.19.02974. Epub 2020 Jan 2. J Clin Oncol. 2020. PMID: 31895609 No abstract available.
122 results